{
    "organizations": [],
    "uuid": "319270031a9c774518533d2aa77bb7cb9b364bce",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/01/31/globe-newswire-agios-to-webcast-conference-call-of-fourth-quarter-and-full-year-2017-financial-results-on-february-14-2018.html",
    "ord_in_thread": 0,
    "title": "Agios to Webcast Conference Call of Fourth and Full Year 2017 Financial on February 14, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a conference call and live webcast on Wednesday, February 14, 2018 at 8:00 a.m. ET to report its fourth quarter and full year 2017 financial results and discuss recent clinical development and corporate activities.\nA live webcast can be accessed under \"Events & Presentations\" in the Investors section of the company's website at www.agios.com . The conference call can be accessed by dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international) and referring to conference ID 3198522. The webcast will be archived and made available for replay on the company's website beginning approximately two hours after the event.\nAbout Agios\nAgios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has an approved oncology precision medicine and multiple first-in-class investigational therapies in clinical and/or preclinical development. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics. For more information, please visit the company's website at www.agios.com .\nAgios Pharmaceuticals:\nRenee Leck, 617-649-8299\nSenior Manager, Investor & Public Relations\nRenee.Leck@agios.com\nSource:Agios Pharmaceuticals, Inc.",
    "published": "2018-02-01T00:01:00.000+02:00",
    "crawled": "2018-02-01T01:40:16.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "cambridge",
        "globe",
        "newswire",
        "agio",
        "pharmaceutical",
        "nasdaq",
        "agio",
        "leader",
        "field",
        "cellular",
        "metabolism",
        "treat",
        "cancer",
        "rare",
        "genetic",
        "disease",
        "today",
        "announced",
        "company",
        "host",
        "conference",
        "call",
        "live",
        "webcast",
        "wednesday",
        "february",
        "et",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "discus",
        "recent",
        "clinical",
        "development",
        "corporate",
        "activity",
        "live",
        "webcast",
        "accessed",
        "event",
        "presentation",
        "investor",
        "section",
        "company",
        "website",
        "conference",
        "call",
        "accessed",
        "dialing",
        "domestic",
        "international",
        "referring",
        "conference",
        "id",
        "webcast",
        "archived",
        "made",
        "available",
        "replay",
        "company",
        "website",
        "beginning",
        "approximately",
        "two",
        "hour",
        "event",
        "agio",
        "agio",
        "focused",
        "discovering",
        "developing",
        "novel",
        "investigational",
        "medicine",
        "treat",
        "cancer",
        "rare",
        "genetic",
        "disease",
        "scientific",
        "leadership",
        "field",
        "cellular",
        "metabolism",
        "addition",
        "active",
        "research",
        "discovery",
        "pipeline",
        "across",
        "therapeutic",
        "area",
        "agio",
        "approved",
        "oncology",
        "precision",
        "medicine",
        "multiple",
        "investigational",
        "therapy",
        "clinical",
        "preclinical",
        "development",
        "agio",
        "program",
        "focus",
        "genetically",
        "identified",
        "patient",
        "population",
        "leveraging",
        "knowledge",
        "metabolism",
        "biology",
        "genomics",
        "information",
        "please",
        "visit",
        "company",
        "website",
        "agio",
        "pharmaceutical",
        "renee",
        "leck",
        "senior",
        "manager",
        "investor",
        "public",
        "relation",
        "source",
        "agio",
        "pharmaceutical",
        "inc"
    ]
}